| Size | Price | Stock | Qty |
|---|---|---|---|
| 1mg |
|
||
| 5mg |
|
||
| 10mg |
|
||
| Other Sizes |
|
| ln Vitro |
MLT-231 (19.5–10,000 nM) prevents OCI-Ly3 cells from proliferating. MLT-231 (50-5000 nM; 24 hours) suppresses the expression of the NF-κB target gene IRF4 while causing the uncleaved forms of its substrates, CYLD, BCL10, and RELB, to accumulate[1].
|
|---|---|
| ln Vivo |
In the ABC-DLBCL xenograft model, MLT-231 (10-100 mg/kg; po; bid schedule for 2 weeks) exhibits in vivo efficacy[1]. Following IV administration of MLT-231 (1 mg/kg) to BALB/c mice, the CL, t1/2, and Vss are, respectively, 11 mL/min/kg, 1.9 hours, and 1.5 L/kg[1]. Following intravenous administration of MLT-231 (1 mg/kg) to Sprague-Dawley rats, the CL, t1/2, and Vss are 41 mL/min/kg, 3.2 hours, and 9.4 L/kg, respectively[1]. The AUC0-24, Cmax, and F values for MLT-231 (3 mg/kg; po; BALB/c mice) are 3096 nM/h, 549 nM, and 99%, respectively[1]. The AUC0-24, Cmax, and F values for MLT-231 (3 mg/kg; po; Sprague-Dawley rats) are 547 nM/h, 46 nM, and 61%, correspondingly.
|
| Cell Assay |
Western Blot Analysis[1]
Cell Types: OCI-Ly3 cells Tested Concentrations: 50-5000 nM Incubation Duration: 24 hrs (hours) Experimental Results: NF-κB target gene IRF4 was suppressed. |
| Animal Protocol |
Animal/Disease Models: Scid-beige mice (OCI-Ly10 ABC-DLBCL type xenograft model)[1]
Doses: 10, 30, and 100 mg/kg Route of Administration: Po; bid schedule for 2 weeks Experimental Results: Led to tumor stasis, while being well tolerated. |
| References |
| Molecular Formula |
C19H19CLF3N7O2
|
|---|---|
| Molecular Weight |
469.848072290421
|
| Exact Mass |
469.124
|
| CAS # |
2682102-10-7
|
| PubChem CID |
146680905
|
| Appearance |
White to off-white solid powder
|
| LogP |
2.6
|
| Hydrogen Bond Donor Count |
2
|
| Hydrogen Bond Acceptor Count |
9
|
| Rotatable Bond Count |
3
|
| Heavy Atom Count |
32
|
| Complexity |
665
|
| Defined Atom Stereocenter Count |
2
|
| SMILES |
C[C@H]1COC[C@@H](N1C2=C(C=NC3=CC(=NN32)Cl)NC(=O)NC4=CC(=NC=C4)C(F)(F)F)C
|
| InChi Key |
BFPCFGGFGQMJQG-QWRGUYRKSA-N
|
| InChi Code |
InChI=1S/C19H19ClF3N7O2/c1-10-8-32-9-11(2)29(10)17-13(7-25-16-6-15(20)28-30(16)17)27-18(31)26-12-3-4-24-14(5-12)19(21,22)23/h3-7,10-11H,8-9H2,1-2H3,(H2,24,26,27,31)/t10-,11-/m0/s1
|
| Chemical Name |
1-[2-chloro-7-[(3S,5S)-3,5-dimethylmorpholin-4-yl]pyrazolo[1,5-a]pyrimidin-6-yl]-3-[2-(trifluoromethyl)pyridin-4-yl]urea
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
DMSO: 110 mg/mL (234.12 mM)
|
|---|---|
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 6 mg/mL (12.77 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 60.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 5.5 mg/mL (11.71 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 55.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly. (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.1283 mL | 10.6417 mL | 21.2834 mL | |
| 5 mM | 0.4257 mL | 2.1283 mL | 4.2567 mL | |
| 10 mM | 0.2128 mL | 1.0642 mL | 2.1283 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
